Market Intelligence Resources
-
Sage Therapeutics Sponsor Briefing Document: Brexanolone Injection, For Intravenous Use, Presented To The Joint Meeting Of The FDA Psychopharmacologic Drug Advisory Committee & Drug Safety & Risk Management Advisory Committee
Market Intelligence Resource | March 29, 2019 -
California Medi-Cal Managed Care Request For Proposal (RFP) Schedule By Model Type
Market Intelligence Resource | March 29, 2019 -
Private Equity Backed Organizations Value To The I/DD Market Through Collaborations With Provider Organizations
White Paper | March 28, 2019 -
Ohio Technology First Council, Session One: The Current Status & Future Possibilities For Technology
Market Intelligence Resource | March 28, 2019 -
North Carolina Behavioral Health & I/DD Tailored Plan Eligibility & Enrollment
Market Intelligence Resource | March 28, 2019 -
Michigan Medicaid Long-Term Services & Supports: Final Report
Market Intelligence Resource | March 28, 2019 -
Frontline Workers In The State Child Protective System: Perspectives On Factors That Impact Effectiveness And Efficiency Of Child Protective Work
Market Intelligence Resource | March 22, 2019 -
The Special Registration For Telemedicine: In Brief
Market Intelligence Resource | March 22, 2019 -
Physician Acceptance Of New Medicaid Patients
Market Intelligence Resource | March 22, 2019 -
Health Professionals For Patients In Pain Letter To CDC Calling For Public Clarification & Impact Evaluation To Address Misapplication Of Its Guideline On Opioids For Chronic Pain
Market Intelligence Resource | March 22, 2019 -
Reforming Bail Practices In Washington
Market Intelligence Resource | March 22, 2019 -
Long-Term Care Providers & Services Users In The United States: 2015-2016
Market Intelligence Resource | March 22, 2019 -
Arizona Executive Order 2019-03: Enhanced Protections For Individuals With Disabilities
Market Intelligence Resource | March 22, 2019 -
Ending The HIV Epidemic: A Plan For America
Market Intelligence Resource | March 22, 2019 -
CMS Approval Of Colorado State Plan Amendment ( SPA) 18- 0044 To Implement Value-Based Pharmaceutical Purchasing
Market Intelligence Resource | March 22, 2019 -
Human Immunodeficiency Virus-1 Infection: Developing Systemic Drug Products For Pre-Exposure Prophylaxis Guidance For Industry
Market Intelligence Resource | March 22, 2019 -
Pediatric HIV Infection: Drug Product Development For Treatment Guidance For Industry
Market Intelligence Resource | March 22, 2019 -
CMS Approval Of Michigan State Plan Amendment ( SPA) 18-0009 To Implement Value-Based Pharmaceutical Purchasing
Market Intelligence Resource | March 22, 2019 -
New York State Children’s Medicaid Transformation Update: Transition To Health Home Care Management & Children’s Waiver
Market Intelligence Resource | March 22, 2019 -
Arizona Governor’s Letter Requesting Investigation Of Hacienda HealthCare
Market Intelligence Resource | March 22, 2019 -
New Mexico Senate Bill 22 – Early Childhood Education & Care Department
Market Intelligence Resource | March 22, 2019 -
New Mexico Senate Bill 28 – Child Protective Custody, Preference To Relatives
Market Intelligence Resource | March 22, 2019 -
New Mexico Governor’s Executive Budget Recommendation For Fiscal Year 2020: July 1, 2019 – June 30, 2020
Market Intelligence Resource | March 22, 2019 -
Do You Have The State-Specific Health Payer Landscape Market Intelligence You Need?
Market Intelligence Resource | March 22, 2019 -
Report Of The New Mexico Legislative Finance Committee To The Fifty-Fourth Legislature; Volume I Legislating For Results: Policy & Performance Analysis
Market Intelligence Resource | March 22, 2019
